Last reviewed · How we verify
NCT07393841: MISFIT
Molecular Indicators of Systematic Fitness
trial testing There is no intervention. in Healthy Adult in 250 participants. Currently enrolling.
5 January 2028
Quick facts
| Lead sponsor | VO Health, Inc. |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 250 |
| Start date | 5 January 2026 |
| Primary completion | 5 January 2028 |
| Estimated completion | 10 May 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- There is no intervention.
Conditions studied
- Healthy Adult — all drugs for Healthy Adult →
- Fitness Testing — all drugs for Fitness Testing →
- Athlete — all drugs for Athlete →
- Aging — all drugs for Aging →
Sponsor
VO Health, Inc.
Who can join
18 and older, any sex, with Healthy Adult or Fitness Testing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to characterize associations between cardiorespiratory fitness, as measured by VO₂max/VO₂peak, and blood-based molecular measurements in adults. This is an observational study where research staff measures VO₂max/VO₂peak and collects fasted, resting blood samples on the same day. The main questions it aims to answer are: 1. Can a multi-analyte blood panel accurately predict directly measured VO₂max/VO₂peak? 2. How do these blood-based features vary across age, sex, and self-reported or documented physical activity profiles? 3. Are the predictor analytes able to capture changes in VO₂max/VO₂peak caused by a self-directed intervention (e.g., training for a marathon)? 4. What is the analytic reliability of the predictor biomarkers?
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07393841
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of There is no intervention.
Trials testing the same drug.
- NCT06113601 — Assessment of Admission to the ICU of Onco-hematological Patients. · unknown
- NCT06016309 — The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis · recruiting
- NCT06347445 — Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus-2 (TEMD-2 Study) · completed
- NCT04804995 — Investigating the Frequency and Phenotype of Headaches Associated With Fasting During the Month of Ramadan. · completed
- NCT04160585 — Individual and Work-Related Risk Factors for Musculoskeletal Pain: a Cross-Sectional Study Among Turkish Office Workers · completed
Other recruiting trials for Healthy Adult
Currently open trials in the same condition.
- NCT07361406 — SweetSpot - The Effect of Non-nutritive Sweeteners on Health · NA · recruiting
- NCT07343245 — A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs · Phase 1 · recruiting
- NCT07414862 — The Effects of Finger Extensor Training on Climbing Performance Compared With Traditional Flexor Training · NA · active not recruiting
- NCT07527247 — Improving Vaccine Protection for Older Adults · Phase 2 · recruiting
- NCT07168122 — Establishment and Clinical Application of Reference Intervals of Salivary Cortisol · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07393841 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by VO Health, Inc.
- Last refreshed: 6 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07393841.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing